Clincosm LogoSign in Get a demo

Hemophilia A

Showing 26 - 50 of 304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Called JOIHA to Learn More About How Well Treatment With Jivi

Recruiting
  • Hemophilia A
  • Prophylaxis of Bleeding
  • Damoctocog alfa pegol (Jivi, BAY94-9027)
  • Multiple Locations, Italy
    Many Locations
Jan 24, 2023

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Hemophilia A Trial in Worldwide (efanesoctocog alfa (BIVV001))

    Completed
    • Hemophilia A
    • efanesoctocog alfa (BIVV001)
    • Los Angeles, California
    • +41 more
    Jan 20, 2023

    Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
    • +3 more
    Jan 18, 2023

    Children, Teenagers and Severe Hemophilia A Who Switched From

    Active, not recruiting
    • Hemophilia A
    • Non-Interventional
    • Hamilton, Ontario, Canada
      Hamilton-Niagara Regional Hemophilia Treatment Centre
    Jan 16, 2023

    Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With

    Recruiting
    • Hemophilia A
    • Damoctocog alfa pegol (Jivi, Bay94-9027)
    • Mobile, Alabama
    • +36 more
    Jan 13, 2023

    Damoctocog Alfa Pegol, How it is Used in Every Day Practice, and

    Not yet recruiting
    • Hemophilia A
    • No intervention
    • Sacramento, California
    • +2 more
    Jan 10, 2023

    Hemophilia A Trial in Worldwide (Emicizumab)

    Completed
    Has Results
    • Hemophilia A
    • Sacramento, California
    • +16 more
    Dec 13, 2022

    Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)

    Recruiting
    • Hemophilia A
    • +3 more
    • Valoctocogene Roxaparvovec
    • Seoul, Korea, Republic of
    • +8 more
    Jan 6, 2023

    Hemophilia A Trial in Worldwide (BAY2599023 (DTX201))

    Active, not recruiting
    • Hemophilia A
    • BAY2599023 (DTX201)
    • Little Rock, Arkansas
    • +12 more
    Jan 5, 2023

    Hemophilia A Trial in Atlanta (aPCC-emicizumab, FEIBA, rFVIIa)

    Not yet recruiting
    • Hemophilia A
    • Atlanta, Georgia
    • +1 more
    Jan 5, 2023

    Hemophilia B, Hemophilia A Trial in Worldwide (Standard of Care FIX Replacement therapy, Standard of Care FVIII Replacement

    Recruiting
    • Hemophilia B
    • Hemophilia A
    • Standard of Care FIX Replacement therapy
    • Standard of Care FVIII Replacement therapy
    • Palo Alto, California
    • +77 more
    Dec 29, 2022

    Hemophilia A Trial in Milwaukee (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human

    Recruiting
    • Hemophilia A
    • Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Dec 21, 2022

    Hemophilia A Trial in Worldwide (valoctocogene roxaparvovec)

    Active, not recruiting
    • Hemophilia A
    • valoctocogene roxaparvovec
    • Los Angeles, California
    • +47 more
    Dec 21, 2022

    Learn More About Physical Activity Level of Patients Suffering

    Recruiting
    • Hemophilia A
    • Damoctocog alfa pegol (Jivi, BAY94-9027)
    • Orange, California
    • +20 more
    Dec 19, 2022

    Hemophilia A, Hemophilia B Trial in Worldwide (PF-06741086)

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Tampa, Florida
    • +62 more
    Dec 14, 2022

    TAK-660 in Surgical Procedures for People With Hemophilia A.

    Active, not recruiting
    • Hemophilia A
    • PEGylated Recombinant Factor VIII
    • Tokyo, Japan
      Takeda Selected Site
    Dec 13, 2022

    Severe Hemophilia Non-Interventional Study

    Not yet recruiting
    • Hemophilia A
    • Hemophilia B
    • No Intervention
    • Rzeszów, Podkarpackie, Poland
    • +2 more
    Dec 8, 2022

    Study Medicines Called Giroctocogene Fitelparvovec and

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Testing of hepatic AAV Vector integration
    • Madison, Mississippi
      Mississippi Center For Advanced Medicine
    Dec 1, 2022

    Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in

    Not yet recruiting
    • Hemophilia A
      • Jinan, Shandong, China
        Shandong Provincial Qianfoshan Hospital, The First Hospital affi
      Dec 2, 2022

      Hemophilia A Trial in Worldwide (Emicizumab)

      Active, not recruiting
      • Hemophilia A
      • Beijing City, China
      • +12 more
      Nov 21, 2022

      Hemophilia A Trial in Metairie, New Orleans (Factor IX)

      Recruiting
      • Hemophilia A
      • Factor IX
      • Metairie, Louisiana
      • +1 more
      Nov 14, 2022

      Hemophilia A Trial in United Kingdom, United States (SIG-001)

      Terminated
      • Hemophilia A
      • SIG-001
      • Indianapolis, Indiana
      • +5 more
      Nov 7, 2022

      Gaining Insight Into the Complexity of Pain in Haemophilia

      Recruiting
      • Hemophilia A
      • Hemophilia B
      • Biopsychological pain assessment
      • Edegem, Antwerp, Belgium
      • +1 more
      Nov 3, 2022

      Hemophilia A Trial in Abidjan (Prophylaxis with Emicizumab)

      Completed
      • Hemophilia A
      • Prophylaxis with Emicizumab
      • Abidjan, Côte D'Ivoire
        CHU de Yopougon
      Oct 24, 2022